342 A phase 1/2 study evaluating the safety, pharmacokinetics and efficacy of ABT-414 in subjects with advanced solid tumors likely to over-express the epidermal growth factor receptor (EGFR)
Year: 2014
Type: article
Source: European Journal of Cancer
Authors: A. Tolcher, G. Goss, M. Gordon, L. Gandhi, K.P. Papadopoulos, D. Rasco, M. Pedersen, J. Fischer, W. Ames, H. Xiong, M. Dudley, W. Munasinghe, P. Ansell, K. Holen, E. Vokes
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2127320503